Selective estrogen receptor modulators regulate reactive microglia after penetrating brain injury

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Microglia activation post-brain injury releases pro-inflammatory molecules, potentially worsening damage.
• Selective estrogen receptor modulators (SERMs) like raloxifene and tamoxifen can reduce microglia activation in young animals.
• Therapeutic strategies to limit microgliosis are of significant interest for brain injury treatment.

Purpose of the Study:

• To investigate the effects of raloxifene and tamoxifen on microglia activation following brain injury in both young and aged rats.
• To assess these effects at clinically relevant time points, hours after trauma.
• To explore potential neuroprotective mechanisms of SERMs in brain trauma.

Main Methods:

• Rats (young and aged) underwent ovariectomy followed by stab wound brain injury.
• Treatment with raloxifene and tamoxifen was administered post-injury.
• Microglia activation was quantified by measuring MHC-II(+) microglia volume fraction and analyzing cellular morphology using fractal analysis.

Main Results:

• Raloxifene and tamoxifen significantly reduced microglia activation in both young and aged rats.
• Aged microglia exhibited a 'bushier' and hyperplasic morphology compared to young microglia, despite a lower overall volume fraction of reactive microglia.
• These findings highlight age-related differences in microglial response to injury.

Conclusions:

• Early regulation of microglia activation by SERMs, including raloxifene and tamoxifen, may offer a neuroprotective effect after brain trauma.
• SERMs demonstrate efficacy in modulating microglia activation across different age groups.
• The study provides insights into the therapeutic potential of SERMs for brain injury recovery.